Abstract: This study was designed to investigate the effect of curcumin (diferuloylmethane) on the proliferation and apoptosis of hepatic stellate cells (HSC). The cell line HSC-T6 (1.25 x 10 5 cells/mL) was incubated with curcumin and HSC proliferation was detected by a methyl thiazolyl tetrazolium colorimetric assay. HSC apoptosis was detected by flow cytometry, transmission electron microscope and agarose gel electrophoresis. HSC proliferation was significantly inhibited in a concentration-dependent manner (10.6 to 63.5%) after incubation with 20-100 μM curcumin, compared with a control group. At 20, 40, and 60 μM, after 24 h of incubation, curcumin was associated with a significant increase in the number of HSC in the G2/M phase, and a significant decrease in cell numbers in the S phase (P < 0.05). At these concentrations, curcumin was also associated with an increase in the apoptosis index of 15.3 ± 1.9, 26.7 ± 2.8, and 37.6 ± 4.4%, respectively, compared to control (1.9 ± 0.6%, P < 0.01). At 40 μM, the curcumininduced apoptosis index at 12, 24, 36, and 48 h of incubation was 12.0 ± 2.4, 26.7 ± 3.5, 33.8 ± 1.8, and 49.3 ± 1.6%, respectively (P < 0.01). In conclusion, curcumin inhibits the in vitro proliferation of HSCs in the G2/M phase of the cell cycle and also induces apoptosis in a concentration-and time-dependent manner. The in vivo effect of curcumin on HSCs requires further investigation. 
Introduction
Hepatic fibrosis is a reversible complication of advanced liver disease and represents a major worldwide health care burden. Hepatic stellate cells (HSC) undergo activation into proliferative and fibrogenic myofibroblast-like cells during liver injury. 1 The imbalance between proliferation and apoptosis of HSC is the main pathogenesis of liver fibrosis. 1,2 Therefore, inhibiting HSC activation and inducing their apoptosis may be important strategies to prevent or treat hepatic fibrosis. 3 Curcumin, also known as Turmeric yellow or diferuloylmethane, is a phenol derived from a herb by the name of Curcuma aromatica salisb. 4 Curcumin has a chemical structure of 1,6-Heptadiene-3,5-dione and a molecular weight of 368. For several decades curcumin has been widely used as a food coloring ingredient for its yellowish color. In the last 10 years, several in vitro and in vivo studies have found that curcumin possesses significant pharmacological actions, such as anti-tumor effects, anti-inflammatory effects and induction of apoptosis of cancer cells.
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The effect of curcumin on HSC and hepatic fibrosis are unknown. The primary aim of this study was to investigate effects of curcumin on the proliferation and apoptosis of HSC cell line in vitro. 
Materials and Methods

Rat
Preparation for curcumin stock solution
Dimethyl sulfoxide (final concentration <1‰) was used to dissolve curcumin. Dulbecco's modified Eagle's medium was added into the stock solution at the concentrations of 10 mmol/L.
A 0.22μm micropore filter was employed to filtrate bacteria. Subpackages of the stock solution were stored and kept away from light at -20°C.
HSC-T6 culture
Cells were cultured in Dulbecco's modified Eagle's medium culture solution, supplemented with 100U/ml penicillin, 100U/ml streptomycin and 10% new-born calf serum. The cell culture was performed at 37℃ under 5% CO 2 , 95% air and saturated humidity in cell culture flask. Culture medium was changed every two days. Cells were digested by 0.25% trypsinase and 0.02%
EDTA as cell density grew to 80% to 90%.
Effect of curcumin on cell proliferation
Influence of curcumin on HSC proliferation was detected by MTT methods. serum were added to every well and cultured for 4 h. Culture solution was removed. Remaining cells were dissolved with 100 μl dimethyl sulfoxide. Absorptance was detected by Enzyme sign machine (ELSIA Reader, Japan) with 630nm reference wavelength and 570nm measure wavelength.
Inhibition ratio = 1-(absorptance of drug group/ absorptance of control group) ×100%.
Flow cytometry test for apoptosis
Cells in logarithmic growth phase were seeded into T-25 culture flasks at 7 × 10 5 /mL density and 
Morphology observation of cell apoptosis
Cells were co-cultured with 40 μmol/L curcumin for 24 h. Suspended and adherent cells were collected and washed with PBS once, and then they were fixed with 2.5% glutaraldehyde at 4℃
for 1 h, and postfixed with 1% osmic acid for 30 min. The cells were stained with lead-uranium and the changes in ultrastructural organization were observed under a Hitachi-600 (Tokyo, Japan) transmission electron microscope.
DNA ladder of cell apoptosis test
Cells were treated with four different concentrations (0, 20, 40,60 μmol/L) of curcumin for 24 h. DNA was extracted as described previously. 12 1.5% agarose gel electrophoresis was performed for 3 h at constant voltage of 50 volt, and observed with gel imaging system (Multi Genius Bioimaging system, SYNGENE, USA).
Statistical analysis
Results were expressed as Means ± SD. Statistical difference were examined by One-way analysis of variance or student t test. Differences were considered to be statistically significant at
P<0.05.
Results
Curcumin and HSC proliferation.
After curcumin treatment, hepatic stellate cell proliferation reduced significantly compared to the control group ( 
Effects of curcumin on cell cycle
As shown in Table 2 , curcumin treatment at a concentration between 10 and 60μmol/L curcumin was associated with no significant changes cell numbers in the G 0 /G 1 (P>0.05 compared with that of the control group). There was a gradual decrease in the number of cells in the S phase, and a gradual increase in the cells in the G2/M phase (P<0.05 and 0.01, respectively), as the curcumin concentrations increased from 10 to 60μmol/L.
Effects of curcumin on cell apoptosis
A significant peak of hypodiploid of apoptosis could be found by flow cytometry when HSCs were incubated with curcumin at 20, 40 and 60μmol/L (Fig 1) , whereas no such peak could be found in the control group. Apoptosis indexes (%) of the curcumin groups were 15.3±1.88%, 26.7±2.79% and 37.6±4.38%, respectively, which were higher than that of control group (1.9±0.64%, P<0.01).
Apoptosis index of HSCs elevated gradually along with the treatment time when the HSCs
were treated with 40μmol/L curcumin (Fig 2) .
Morphology of HSC
After incubated with 40μmol/L of curcumin for 24h, HSCs became smaller under the contrast phase microscope (Fig 3) . Nuclear chromatin enriched to globular, and chromatin condensation ranked along inside of nuclear membrane. Condensed organelle and apoptotic body could be observed by transmission electron microscope (Fig 4) . 9 
DNA fragment detection
A high molecular weight strap was found on the top of the agarose gel of the control group ( Fig   5) . Meanwhile, DNA ladder could be found after treatment at 20, 40 and 60μmol/L of curcumin (Fig 5) .
Discussion
The major findings of our study are: 1) Curcumin concentration-dependently inhibits HSC proliferation in vitro; 2) Curcumin concentration-dependently reduces the number of cells in the S phase, and increases the cells in the G2/M phase; 3) Curcumin induces apoptosis of hepatic stellate cells in a cocnentration-and time-dependent manner.
Because of the critical role of HSC in the pathogenesis of hepatic fibrosis genesis, induction of HSC apoptosis has become potentially important prevention or treatment of hepatic fibrosis.
Enhanced HSC apoptosis may reduce the substrate of collagen genesis and increase extracellular matrix degradation, assisting the recovery of hepatic fibrosis. Our in vitro study clearly demonstrated that curcumin can induce HSC apoptosis, and suppress the proliferation of HSCs in the S phase. Curcumin not only inhibits HSC proliferation and induces apoptosis, but also inhibits the transformation of HSC from quiescent phenotype to activated phenotype, and decreases the expression of αlpha-SMA, a marker of HSC activation. 13, 14 Curcumin also reduces the secretion of collagentype I in HSC in vitro, and the collagen deposition in the liver of hepatic fibrotic rats induced by carbon tetrachloride. 13, 14 An earlier human study showed that in a group of volunteer treated with 8 g curcumin each day for three months, no significant side effects were observed. 15 These results suggest that curcumin may be safely used to treat hepatic fibrosis 10 through several different mechanisms.
The signaling pathways by which curcumin affects cell proliferation and apoptosis are not entirely clear. In rat HSC, the inhibition of cell proliferation and induction of apoptosis appears to be related to the activation of peroxisome proliferator, 16 a key regulator of the cell cycle and apoptosis. In Hodgkin's lymphoma cells, the effect of curcumin on the cells is associated with the inhibition of constitutively active NF-kappaB and STAT3 pathways, leading to a decreased expression of proteins involved in cell proliferation and apoptosis, e.g. Bcl-2, Bcl-xL. 17 Also in
Hodgkin's lymphoma cells, curcumin triggers apoptosis by activating caspase-3 and caspase-9, and by changing the nuclear morphology and phosphatidylserine translocation. 17 In human acute myelogenous leukemia HL-60 cells, curcumin is also found to induce apoptosis through mitochondrial pathway involving caspase-8, BID cleavage, cytochrome C release, and caspase-3 activation. 7 It is uncertain how these signaling pathways or their interplay would have contributed to the significant effect of curcumin on cell growth and apoptosis in our study. The precise signaling pathways leading to proliferation inhibition and apoptosis induction needs to be further investigated.
In summary, we found that curcumin significantly inhibits proliferation and induces apoptosis of hepatic stellate cells in vitro. Further clinical studies are warranted to evaluate the safety and efficacy of this agent in the management of hepatic fibrosis. Fig 1a) , and after treatment of curcumin at 20 (Fig 1b), 40 (Fig 1c) and 60 μmol/L (Fig 1d) . 
